Don’t miss the chance to meet us in Medica 2023, in Düsseldorf, Germany We’re tirelessly advancing the development of cutting-edge point-of-care diagnostic tests for the future. In the upcoming week, we’re excited to announce our participation in Medica 2023, 13-16 November 2023. We invite you to schedule a meeting with our team, eager to provide…
Upcoming participation in the highly anticipated Medical Biodefense Conference 2023 Selfdiagnostics is proud to announce that our dedicated team will be presenting an informative poster session titled: “Rapid and Precise RNA/DNA detection on-stie using Instrument-free Multitest” This presentation will shed light on our groundbreaking Multitest technology, a cutting-edge solution for the rapid and precise detection…
Getting ready for mass production of Selfdiagnostics Multitest Covid-19 in Germany Selfdiagnostics has set up a fully functional production line in Germany. The newly set up production site is equipped with cutting-edge technology for a cost-efficient and high-quality manufacturing. With the completion of internal product validation, Selfdiagnostics targets to produce and market 1 million devices…
After years of research and development, Selfdiagnostics brings a portable and pocket-size test to the market to detect SARS-CoV-2 in 45 minutes. The CE marked Multitest COVID-19 is registered in German Medical Device Information and Database System (DMIDS) and in European Database on Medical Devices (EUDAMED). FDA and other certifications will follow. The 2019 outbreak…
Selfdiagnostics SARS-CoV-2 IgM/IgG Antibody Assay Kit is a rapid, accurate and straightforward point-of-care test kit that qualitatively detects IgM and IgG antibodies against the virus that causes COVID-19. The test detects specific SARS CoV2 IgG and IgM antibodies in the blood in response to a coronavirus infection. The detection of antibodies can be used to…
Selfdiagnostics began development of a rapid SARS-CoV-2 test which enables faster detection of coronavirus infection at a lower price. The new rapid test will significantly increase testing capacity and deliver greater resource efficiency. The project has been awarded an EIT Health product development grant by the European Institute of Innovation and Technology. The rapid test…
For some time now, the healthcare system has been moving towards patients. However, we are still only halfway. During the last few months, we have witnessed the critical importance of both next-to-patient testing from doctors and self-testing at home. These methods not only avoid the fast-spreading of infections but also enables starting treatment as fast…
The Estonian company Selfdiagnostics brings laboratory-grade precision home medical testing to ordinary users and offers the world’s smallest application of PCR technology. This unique product paves the way for bigger changes in medicine in regard to patients taking the first steps toward diagnosing illnesses. Founded in 2008, the company originally looked to market a patient-side…
Selfdiagnostics STD Multitest – a next generation molecular diagnostics technology based rapid test will have its first worldwide appearance at MEDICA 2017. STD Multitest is the first and only rapid chlamydia and gonorrhoea duplex test in the world. It is painless, can be used by both sexes, provides reliable results in 30 minutes and utilises technology…
Selfdiagnostics’ work within the frames of Horizon 2020 project was evaluated by European Commission experts and an interim assessment report was recently completed. The experts found that our project is compliant with H2020 regulations and has achieved objectives and milestones set for the reporting period. Experts have confidence that Selfdiagnostics will provide results with significant immediate…
